Late Pregnancy · Preterm Risk
QUiPP App — Preterm Birth Risk
Free clinical app that calculates personalised preterm birth risk from fFN + cervical length + history. NICE-supported decision aid. Informs admission, steroids, magnesium, transfer decisions. EQUIPTT trial 2020.
Last reviewed 2 June 2026
NICE-endorsed individual risk prediction
This page describes the QUiPP App.
QUiPP is a free, validated, NICE-endorsed mobile app — we don’t replicate the algorithm here because the official app is the canonical implementation. The 5 inputs and what they represent are explained below.
Open quipp.orgThe 5 inputs QUiPP uses
What QUiPP outputs
- Probability of spontaneous preterm birth within 2 weeks of test
- Within 4 weeks of test
- Before 30 weeks gestation
- Before 34 weeks
- Before 37 weeks
Outputs are presented as % risk with confidence intervals; outperforms any single predictor used alone.
What is QUiPP?
Free clinical app that calculates preterm birth risk using quantitative fetal fibronectin (qfFN) + cervical length + maternal history. NICE-supported decision aid.
Developed by Andrew Shennan / King’s College London. Used in UK NHS, US, and globally.
What goes in
- Quantitative fFN (qfFN) in ng/mL.
- Cervical length on TVUS in mm.
- Gestational age.
- Parity.
- Previous preterm birth history.
- Symptoms.
- Multiple pregnancy status.
What comes out
Percentage probability of delivery in: 14 days, 30 days, before 30 weeks, before 34 weeks, before 37 weeks.
Clinical decisions it informs
- Admit vs discharge.
- Antenatal steroids if 24-34 wk.
- Magnesium sulphate if <32 wk + imminent.
- In-utero transfer to specialist NICU.
- Tocolysis to delay 48h.
- Routine surveillance schedule.
- Parent counselling.
How accurate?
EQUIPTT trial 2020: QUiPP-guided care reduced unnecessary admissions + interventions vs standard care.
High NPV — low-risk women safely discharged. Moderate PPV — identifies women warranting treatment.
If high risk
- Hospital admission.
- Steroids 24-34 wk.
- Magnesium sulphate <32 wk + imminent delivery.
- Tocolysis 24-48h for steroid effect.
- In-utero transfer if early gestation.
- Intensive monitoring.
If low risk
Reassuring. Safety-net advice; home if otherwise well; follow-up scan / fFN in days-weeks. <1% chance of delivery within 14 days with very low QUiPP.
Alternatives
- PartoSure (PAMG-1).
- Actim Partus (phIGFBP-1).
- Cervical length alone.
- fFN alone.
QUiPP advantages: free, NICE-supported, multimodal.
Different scenarios
Scenario 1: 28 weeks, contractions, QUiPP 18%
Moderate-high. Steroids. Tocolysis 48h. Admit. Possible transfer.
Scenario 2: 30 weeks, fFN positive but cervix 25 mm, QUiPP 3%
Low overall risk. Safety-net + home. Repeat assessment if symptoms continue.
Scenario 3: Previous 30-wk delivery, this pregnancy 26 wk, cervix 20 mm
High-risk surveillance. QUiPP guides cervical length + fFN frequency. Progesterone in place.
Scenario 4: 32 weeks, twins, contractions, QUiPP 25%
High risk. Steroids. Admit. Tocolysis. NICU prep for twins.
Scenario 5: 34 weeks, mild contractions, QUiPP 1%
Very low risk. Safety-net + home. No steroids needed.
Care guidance — QUiPP
- Used in symptomatic + high-risk asymptomatic women.
- Combines fFN + cervical length + history.
- Guides admission, steroids, magnesium, transfer.
- NICE-supported.
- Better than individual tests alone.
- Shared decision-making with team.
- Available free for clinicians on app stores.
Sources
- NICE NG25. Preterm labour and birth.
- Watson HA, et al. EQUIPTT trial: QUiPP app vs standard care for preterm birth prediction. PLoS Med 2020.
- QUiPP App. quipp.org.
Recommended for this calculator